Memantine approved to treat moderate to severe Alzheimer's disease.
Marder
Karen
K
D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy* / Q000503:physiopathology; D004311:Double-Blind Method; D018691:Excitatory Amino Acid Antagonists / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008559:Memantine / Q000627:therapeutic use*; D010919:Placebos
D018691:Excitatory Amino Acid Antagonists; D010919:Placebos; D008559:Memantine